Cinpathogen’s mission is to develop a center of excellence for molecular pathology research in China to improve the diagnosis, management and treatment of hematopoetic and lymphoid diseases for all Chinese citizens.
Cinpathogen directs and manages the Fudan-Cinpathogen Clinical and Molecular Research Center (CMRC) within the Institutes of Biomedical Sciences at Fudan University:
.
By offering molecular diagnostics that meet Western standards, we ensure that patients in Shanghai and the surrounding area benefit from improved diagnosis, as well as disease management and treatment.
Global presence
Cinpathogen has a presence in both the United States and China, including a new state-of-the-art laboratory in Pudong.
See where we work
Our history
Cinpathogen researchers have been integrating Western and Chinese medical research systems since 1999.
Explore our history
Our thinking
Our thinking and research is being published in leading journals.
Read our thinking
Cinpathogen has a presence in both the United States and China, including a new state-of-the-art laboratory in Pudong.
See where we work
Our history
Cinpathogen researchers have been integrating Western and Chinese medical research systems since 1999.
Explore our history
Our thinking
Our thinking and research is being published in leading journals.
Read our thinking
